Reducing Local Recurrence of Adamantinomas
The international multicenter study by Schutgens et al. in the October 7, 2020 issue of JBJS reports findings from …
Giant-Cell Tumor Treatment: Curettage Without Denosumab Is Better
Denosumab is an FDA-approved drug for osteoporosis. It works by binding RANKL, thus inhibiting osteoclastic activity. Denosumab  has also been …